Merit Medical Systems (MMSI) Receiving Somewhat Positive Media Coverage, Report Finds
News headlines about Merit Medical Systems (NASDAQ:MMSI) have been trending somewhat positive this week, according to Accern Sentiment. Accern identifies negative and positive media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Merit Medical Systems earned a coverage optimism score of 0.09 on Accern’s scale. Accern also gave headlines about the medical instruments supplier an impact score of 45.9478151181859 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Merit Medical Systems (NASDAQ MMSI) opened at $43.25 on Tuesday. The company has a market cap of $2,140.98, a PE ratio of 70.90, a price-to-earnings-growth ratio of 2.53 and a beta of 1.29. Merit Medical Systems has a 12-month low of $27.25 and a 12-month high of $48.10. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.78 and a quick ratio of 1.43.
A number of analysts recently weighed in on MMSI shares. Canaccord Genuity upped their target price on shares of Merit Medical Systems from $45.00 to $47.50 and gave the company a “buy” rating in a research note on Thursday, October 26th. Zacks Investment Research raised shares of Merit Medical Systems from a “hold” rating to a “buy” rating and set a $43.00 target price on the stock in a research note on Saturday, October 28th. SunTrust Banks set a $47.00 target price on shares of Merit Medical Systems and gave the company a “buy” rating in a research note on Thursday, November 16th. ValuEngine raised shares of Merit Medical Systems from a “hold” rating to a “buy” rating in a research note on Tuesday, November 21st. Finally, Wells Fargo & Co reissued an “outperform” rating and issued a $51.00 target price (up previously from $46.00) on shares of Merit Medical Systems in a research note on Thursday, November 30th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and ten have assigned a buy rating to the company. Merit Medical Systems currently has a consensus rating of “Buy” and a consensus target price of $43.77.
Merit Medical Systems Company Profile
Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.